|
HY-101287-10mg
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101287-100mg
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101287-25mg
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101287-5mg
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101287-50mg
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101287-1mL
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-N3121-10mg
|
MedChemexpress LLC
|
Pachypodol [CAS 33708-72-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N3121-5mg
|
MedChemexpress LLC
|
Pachypodol [CAS 33708-72-4]
|
|
Cancer-programmed cell death
|
|
|
HY-147027-10mg
|
MedChemexpress LLC
|
PARP-1-IN-2 [CAS 684234-55-7]
|
|
Cancer-programmed cell death
|
|
|
HY-147027-25mg
|
MedChemexpress LLC
|
PARP-1-IN-2 [CAS 684234-55-7]
|
|
Cancer-programmed cell death
|
|
|
HY-147027-5mg
|
MedChemexpress LLC
|
PARP-1-IN-2 [CAS 684234-55-7]
|
|
Cancer-programmed cell death
|
|
|
HY-126437C-10mg
|
MedChemexpress LLC
|
Poly-L-lysine (hydrobromide) (MW 150000-300000) [CAS 25988-63-0]
|
|
|
|
|
HY-126437C-25mg
|
MedChemexpress LLC
|
Poly-L-lysine (hydrobromide) (MW 150000-300000) [CAS 25988-63-0]
|
|
|
|
|
HY-126437C-5mg
|
MedChemexpress LLC
|
Poly-L-lysine (hydrobromide) (MW 150000-300000) [CAS 25988-63-0]
|
|
|
|
|
HY-126437C-50mg
|
MedChemexpress LLC
|
Poly-L-lysine (hydrobromide) (MW 150000-300000) [CAS 25988-63-0]
|
|
|
|
|
HY-15888A-10mg
|
MedChemexpress LLC
|
PTC-209 (hydrobromide) [CAS 1217022-63-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-15888A-100mg
|
MedChemexpress LLC
|
PTC-209 (hydrobromide) [CAS 1217022-63-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-15888A-25mg
|
MedChemexpress LLC
|
PTC-209 (hydrobromide) [CAS 1217022-63-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-15888A-5mg
|
MedChemexpress LLC
|
PTC-209 (hydrobromide) [CAS 1217022-63-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-15888A-50mg
|
MedChemexpress LLC
|
PTC-209 (hydrobromide) [CAS 1217022-63-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-15888-10mg
|
MedChemexpress LLC
|
PTC-209 [CAS 315704-66-6]
|
|
Cancer-programmed cell death
|
|
|
HY-15888-100mg
|
MedChemexpress LLC
|
PTC-209 [CAS 315704-66-6]
|
|
Cancer-programmed cell death
|
|
|
HY-15888-5mg
|
MedChemexpress LLC
|
PTC-209 [CAS 315704-66-6]
|
|
Cancer-programmed cell death
|
|
|
HY-15888-50mg
|
MedChemexpress LLC
|
PTC-209 [CAS 315704-66-6]
|
|
Cancer-programmed cell death
|
|
|
HY-15888-1mL
|
MedChemexpress LLC
|
PTC-209 [CAS 315704-66-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
